| Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study H Jókai, J Szakonyi, O Kontár, M Marschalkó, K Szalai, S Kárpáti, P Holló Journal of the American Academy of Dermatology 69 (4), 523-529, 2013 | 93 | 2013 |
| Successful treatment of lichen planus with adalimumab. P Holló, J Szakonyi, D Kiss, H Jokai, A Horváth, S Kárpáti Acta dermato-venereologica 92 (4), 2012 | 41 | 2012 |
| Intralesional therapy for the treatment of keratoacanthoma N Kiss, P Avci, A Bánvölgyi, K Lőrincz, J Szakonyi, N Gyöngyösi, L Fésűs, ... Dermatologic Therapy 32 (3), e12872, 2019 | 31 | 2019 |
| Coexistence of primary cutaneous anaplastic large cell lymphoma and mycosis fungoides in a patient with B‐cell chronic lymphocytic leukaemia M Marschalkó, J Csomor, N Erős, A Szigeti, J Hársing, J Szakonyi, ... British Journal of Dermatology 157 (6), 1291-1293, 2007 | 20 | 2007 |
| Retrospective analysis of clinicopathological characteristics of pregnancy associated melanoma M Fábián, V Tóth, B Somlai, J Hársing, E Kuroli, F Rencz, ... Pathology & Oncology Research 21, 1265-1271, 2015 | 18 | 2015 |
| Comparative analysis of IL 6 and IL 6 receptor gene polymorphisms in mastocytosis E Rausz, A Szilágyi, B Nedoszytko, M Lange, M Niedoszytko, ... British journal of haematology 160 (2), 216-219, 2013 | 18 | 2013 |
| Cutaneous lymphocyte‐associated antigen as a novel predictive marker of TNF‐alpha inhibitor biological therapy in psoriasis H Jókai, J Szakonyi, O Kontár, G Barna, D Inotai, S Kárpáti, P Holló Experimental Dermatology 22 (3), 221-223, 2013 | 15 | 2013 |
| Imuthiol inhibits the etoposide-induced apoptosis in HL-60 cells E Nagy, J Szakonyi, P Gergely Immunology letters 64 (1), 1-4, 1998 | 12 | 1998 |
| Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study D Kuzmanovszki, N Kiss, B Tóth, T Kerner, V Tóth, J Szakonyi, K Lőrincz, ... Biomedicines 10 (7), 1737, 2022 | 11 | 2022 |
| Tissue-specific homing of immune cells in malignant skin tumors H Jókai, M Marschalkó, J Csomor, J Szakonyi, O Kontár, G Barna, ... Pathology & Oncology Research 18, 749-759, 2012 | 10 | 2012 |
| Melanoma screening in a Hungarian nuclear power plant V Tóth, B Somlai, Z Hatvani, J Szakonyi, I Gaudi, S Kárpáti Pathology & Oncology Research 19, 323-328, 2013 | 8 | 2013 |
| Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two cases N Erős, M Marschalkó, K Balassa, B Hídvégi, J Szakonyi, S Ilniczky, ... Journal of neuro-oncology 97, 301-304, 2010 | 4 | 2010 |
| Association of chronic hepatitis C infection and lichen planus B Podanyi, G Lengyel, A Kiss, J Szakonyi, Z Schaff, J Feher ORVOSI HETILAP 147 (12), 547, 2006 | 4 | 2006 |
| Persistent agmination of lymphomatoid papulosis: a new case with immunohistopathologically confirmed mycosis fungoides component J Csomor, N Erős, Á Szepesi, B Csernus, J Szakonyi, O Kontár, ... Journal of the American Academy of Dermatology 65 (3), e98-e100, 2011 | 3 | 2011 |
| Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study D Kuzmanovszki, N Kiss, B Tóth, V Tóth, J Szakonyi, K Lőrincz, J Hársing, ... Journal of Clinical Medicine 12 (18), 5966, 2023 | 2 | 2023 |
| Immunohistochemical study of the PD-1/PD-L1 pathway in cutaneous lupus erythematosus Z Király, Á Szepesi, A Sebestyén, E Kuroli, F Rencz, B Tóth, L Bokor, ... Pathology& Oncology Research 28, 1610521, 2022 | 1 | 2022 |
| „Art nouveau” mycosis fungoides E Kuroli, M Marschalkó, J Szakonyi, J Csomor Hematológia–Transzfuziológia 53 (2), 130-131, 2020 | 1 | 2020 |
| EORTC Cutaneous Lymphoma Task Force Meeting–St. Gallen, 2018. szeptember 27–29. J Szakonyi Hematológia–Transzfuziológia 51 (3), 162-164, 2018 | 1 | 2018 |
| Association of chronic hepatitis C and lichen planus--in two patients B Podányi, G Lengyel, A Kiss, J Szakonyi, Z Schaff, J Fehér Orvosi Hetilap 147 (12), 547-550, 2006 | 1 | 2006 |
| Investigation of the reactivity patterns of antifilaggrin antibodies in sera and synovial fluids from patients with rheumatoid arthritis using citrullinated synthetic peptides M Brózik, J Szakonyi, A Magyar, B Rojkovich, R Tobi, F Hudecz, ... Arthritis Res Ther 5, 1-1, 2003 | 1 | 2003 |
